Lenz, G., Trneny, M., Burke, J. M., Nowakowski, G. S., Fox, C. P., Chiappella, A., Dull, J., Jeon, Y., Cheah, C., Westin, J., Ye, J. Z., Caguioa, P. B., Belada, D., Shin, H. J., Oh, S. Y., Amorim, S., Colucci, P., Ioannidis, S., Cheng, L., Vitolo, U. (2026). frontMIND: Phase 3 study of tafasitamab (Tafa) plus lenalidomide (Len) and R-CHOP for patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba7000